Squarepoint
ZOM

Squarepoint’s Zomedica Corp. ZOM Stock Holding History

Squarepoint’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64,350
Closed -$7.72K – 5642
2024
Q4 		$7.72K Buy
+64,350
New +$8.1K ﹤0.01% 4962
2023
Q3 		– Sell
-319,297
Closed -$63.9K – 4403
2023
Q2 		$63.9K Buy
+319,297
New +$64.8K ﹤0.01% 3423
2023
Q1 		– Sell
-62,534
Closed -$10.2K – 4018
2022
Q4 		$10.2K Buy
62,534
+36,700
+142% +$7.52K ﹤0.01% 3122
2022
Q3 		$5K Buy
+25,834
New +$6.84K ﹤0.01% 2927
2022
Q2 		– Sell
-75,900
Closed -$26K – 3631
2022
Q1 		$26K Buy
75,900
+30,200
+66% +$9.88K ﹤0.01% 2707
2021
Q4 		$14K Buy
45,700
+12,122
+36% +$5.46K ﹤0.01% 3095
2021
Q3 		$18K Buy
33,578
+15,306
+84% +$9.03K ﹤0.01% 2825
2021
Q2 		$15K Buy
18,272
+6,536
+56% +$6.09K ﹤0.01% 3150
2021
Q1 		$19K Buy
+11,736
New +$19.2K ﹤0.01% 3031

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Squarepoint's ZOM Position: Q1 2025 in Review

Squarepoint sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 64,350 shares — an estimated $7.72K sold.

Squarepoint first reported a position in ZOM in Q1 2021 and held it in 9 quarters. The position peaked at $63.9K in Q2 2023. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Squarepoint reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 64,350 Zomedica Corp. shares in Q1 2025, an estimated $7.72K.
  • Squarepoint first reported a position in Zomedica Corp. in Q1 2021 and held it in 9 quarters.
  • Squarepoint's Zomedica Corp. position peaked at $63.9K in Q2 2023.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.